Basilea Pharmaceutica's Toctino(R) (alitretinoin) Receives Marketing Authorization in Finland
BASEL, SWITZERLAND--(Marketwire - October 15, 2008) - Basilea Pharmaceutica Ltd. announces that Toctino® (alitretinoin), a new once-daily oral treatment for adults with severe chronic hand eczema (CHE) unresponsive to potent topical corticosteroids, has been approved by Finland's National Agency for Medicines (NAM).